| Description |
xi, 283 pages ; 25 cm |
| Note |
"An Institute for Policy Innovation Book." |
| Bibliography |
Includes bibliographical references (pages 241-271) and index. |
| Contents |
Rising expectations-- and diminishing returns -- Property generally : externalities, coordination, and the public domain -- Intellectual property: the public domain and private rights -- Taming conflict of interests -- Federally sponsored research under Bayh-Dole -- The anticommons -- The single monopoly : current patent limitations -- Rate regulation : an unneeded swamp -- Patent purchases: a second swamp -- Socialization of R & D : the final swamp -- The steady expansion of FDA power -- FDA versus the individual : upstream or downstream decision making -- Drug withdrawal : too much, too soon -- Getting the drugs to market -- Deceptive marketing -- Tort preliminaries -- Product liability for prescription drugs : manufacturing and design cases -- The main event : misrepresentation, overpromotion, and duty to warn -- Conclusion : socialized medicines. |
| Subject |
Pharmaceutical industry -- Government policy -- United States.
|
|
Pharmaceutical industry -- Government policy. |
|
United States. |
|
Pharmaceutical industry. |
|
United States. Food and Drug Administration.
|
|
United States. Food and Drug Administration. |
| Added Author |
Yale University. Institute for Policy Innovation.
|
| ISBN |
0300116640 cloth alkaline paper |
|
9780300116649 cloth alkaline paper |
| Standard No. |
9780300116649 |
|
